Noninvasive prenatal diagnosis using next-generation sequencing

Gynecologic and Obstetric Investigation

Volumn 77, Issue 2, 2014, Pages 73-77

  Xu, Liang ^b   Shi, Rui ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Tongji University   (China)

Author keywords

Circulating fetal DNA; Next generation sequencing; Noninvasive prenatal diagnosis

Indexed keywords

DNA; NUCLEIC ACID;

CELL FREE DNA; DIAGNOSTIC PROCEDURE; GENETIC DISORDER; GENETIC SCREENING; HUMAN; HUMAN GENOME; NEXT GENERATION SEQUENCING; NON INVASIVE PROCEDURE; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; ANEUPLOIDY; CHORION VILLUS SAMPLING; DOWN SYNDROME; HAPLOTYPE; PRENATAL SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; TRISOMY 21; BLOOD; DEVICES; DNA SEQUENCE; FEMALE; FETOMATERNAL TRANSFUSION; GENETIC DISEASES, INBORN; PREGNANCY; PROCEDURES;

FEMALE; GENETIC DISEASES, INBORN; GENETIC TESTING; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84896314812     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000355693     Document Type: Review

References (38)

1. Antonarakis SE, Beckmann JS: Mendelian disorders deserve more attention. Nat Rev Genet 2006; 7: 277-282.
2. Costa T, Scriver CR, Childs B: The effect of Mendelian disease on human health: A measurement. Am J Med Genet 1985; 21: 231-242.
3. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B: Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1: 1287-1293.
4. American College of Obstetricians and Gynecologists: ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007; 110: 1459-1467.
5. Jauniaux E, Pahal GS, Rodeck CH: What invasive procedure to use in early pregnancy. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 651-662.
6. Chan KC, Zhang J, Hui AB, et al: Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50: 88-92.
7. Lo YM, Corbetta N, Chamberlain PF, et al: Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
8. Guibert J, Benachi A, Grebille AG, Ernault P, Zorn JR, Costa JM: Kinetics of SRY gene appearance in maternal serum: Detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod 2003; 18: 1733-1736.
9. Chim SS, Tong YK, Chiu RW, et al: Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005; 102: 14753-14758.
10. Masuzaki H, Miura K, Yoshiura KI, Yoshimura S, Niikawa N, Ishimaru T: Detection of cell free placental DNA in maternal plasma: Direct evidence from three cases of confined placental mosaicism. J Med Genet 2004; 41: 289-292.
11. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM: Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64: 218-224.
12. Rijnders RJ, Christiaens GC, Soussan AA, van der Schoot CE: Cell-free fetal DNA is not present in plasma of nonpregnant mothers. Clin Chem 2004; 50: 679-681, author reply 681.
13. Smid M, Galbiati S, Vassallo A, et al: No evidence of fetal DNA persistence in maternal plasma after pregnancy. Hum Genet 2003; 112: 617-618.
14. Nygren AO, Dean J, Jensen TJ, et al: Quantification of fetal DNA by use of methylationbased DNA discrimination. Clin Chem 2010; 56: 1627-1635.
15. Rijnders RJ, der Schoot CE v, Bossers B, de Vroede MA, Christiaens GC: Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001; 98: 374-378.
16. Chiu RW, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YM: Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: A feasibility study. Clin Chem 2002; 48: 778-780.
17. Devaney SA, Palomaki GE, Scott JA, Bianchi DW: Noninvasive fetal sex determination using cell-free fetal DNA: A systematic review and meta-Analysis. JAMA 2011; 306: 627-636.
18. Finning KM, Martin PG, Soothill PW, Avent ND: Prediction of fetal D status from maternal plasma: Introduction of a new noninvasive fetal RHD genotyping service. Transfusion (Paris) 2002; 42: 1079-1085.
19. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B: Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000; 46: 301-302.
20. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM: Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002; 360: 998-1000.
21. Li Y, Di NE, Vitucci A, Zimmermann B, Holzgreve W, Hahn S: Detection of paternally inherited fetal point mutations for beta-Thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005; 293: 843-849.
22. Levine RJ, Qian C, Leshane ES, et al: Twostage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004; 190: 707-713.
23. Lo YM, Leung TN, Tein MS, et al: Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45: 184-188.
24. Ng EK, Leung TN, Tsui NB, et al: The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 2003; 49: 727-731.
25. Oudejans CB, Go AT, Visser A, et al: Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem 2003; 49: 1445-1449.
26. Ding C, Chiu RW, Lau TK, et al: MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004; 101: 10762-10767.
27. Lo YM, Tsui NB, Chiu RW, et al: Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007; 13: 218-223.
28. Chiu RW, Chan KC, Gao Y, et al: Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008; 105: 20458-20463.
29. Chen EZ, Chiu RW, Sun H, et al: Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011; 6:e21791.
30. Bell CJ, Dinwiddie DL, Miller NA, et al: Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011; 3: 65ra4.
31. Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR: Non-invasive prenatal measurement of the fetal genome. Nature 2012; 487: 320-324.
32. Kitzman JO, Snyder MW, Ventura M, et al: Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 2012; 4: 137ra76.
33. Kong A, Frigge ML, Masson G, et al: Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012; 488: 471-475.
34. Goldstein DB: Growth of genome screening needs debate. Nature 2011; 476: 27-28.
35. Costa JM, Benachi A, Gautier E: New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002;346:1502.
36. Lo YM, Hjelm NM, Fidler C, et al: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738.
37. Ehrich M, Deciu C, Zwiefelhofer T, et al: Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-e11.
38. Chiu RW, Akolekar R, Zheng YW, et al: Noninvasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 2011;342: C7401.